SLC33A1 Knockout HCT 116 Cell Line
Cat.No.:
EDC07721
Species:
Human
Cell Name:
HCT 116
Gene:
SLC33A1
Gene ID:
9197
Size:
1×10⁶cells
SLC33A1 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07721 |
|---|---|
| Product Name | SLC33A1 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Gene ID | |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC33A1 |
| Gene Synonyms | ACATN|AT-1|AT1|CCHLND|HPBDS|SPG42 |
| Summary |
The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
|
| Associated Diseases | Colorectal Carcinoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC33A1 function, SLC33A1 Knockout HCT 116 Cell Line or SLC33A1 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC33A1 (AT-1)'s role as the principal ER acetyl-CoA transporter or modeling hereditary spastic paraplegia type 42 and congenital cataracts. The Knockout line is the standard tool for asking whether AT-1 is required for delivering acetyl-CoA to the ER lumen for protein acetylation — AT-1 is the only known ER acetyl-CoA importer, essential for substrate supply to ER acetyltransferases like ATase1/ATase2. Overexpression is useful for studying disease-associated AT-1 mutations or for biochemical reconstitution.
For ER acetylation research, the EDITGENE SLC33A1 Knockout in HCT 116 is highly informative — AT-1 loss disrupts ER protein quality control, ER stress responses, and reticulophagy. SLC33A1 mutations cause SPG42 (autosomal dominant) and CATIFA syndrome (autosomal recessive) — disease variant rescue enables genotype-function correlation studies. Rescue with wild-type or transport-deficient AT-1 is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• ER acetyl-CoA transport: in vitro acetyl-CoA uptake assays using isolated ER microsomes from knockout versus wild-type cells.
• ER protein acetylation: analysis of BiP/GRP78, calreticulin, and other ER protein acetylation status by mass spectrometry.
• ER stress and reticulophagy: ATF6, IRE1, PERK pathway activation and ER-phagy flux measurement given AT-1's role in ER homeostasis.
• SPG42/CATIFA modeling: rescue with disease-associated SLC33A1 mutations for genotype-function studies.
EDITGENE recommends this model for researchers investigating ER acetyl-CoA biology, hereditary spastic paraplegia, and ER protein quality control.
Is this SLC33A1 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. AT-1 rescue experiments require attention to ER membrane targeting:
• Construct design: use a codon-modified SLC33A1 sequence with a small C-terminal tag (FLAG, HA). AT-1 has 11 transmembrane domains with ER targeting determinants.
• ER localization validation: confirm ER localization by calnexin or PDI co-staining before functional assays.
• Disease mutation rescue: SPG42-associated dominant mutations and CATIFA syndrome-associated recessive mutations enable comprehensive disease genotype-function studies.
• Functional readout: rescue should restore ER acetyl-CoA transport (in vitro microsomal assays) and ER protein acetylation status (mass spectrometry).
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download